000 | 01176 a2200349 4500 | ||
---|---|---|---|
005 | 20250517082859.0 | ||
264 | 0 | _c20171211 | |
008 | 201712s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.7590 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLin, Ziying | |
245 | 0 | 0 |
_aThe prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures. _h[electronic resource] |
260 |
_bOncotarget _cMar 2016 |
||
300 |
_a15033-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis | ||
650 | 0 | 4 |
_aB7-H1 Antigen _xmetabolism |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms _xmetabolism |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aXu, Yutong | |
700 | 1 | _aZhang, Yaxiong | |
700 | 1 | _aHe, Qihua | |
700 | 1 | _aZhang, Jianrong | |
700 | 1 | _aHe, Jianxing | |
700 | 1 | _aLiang, Wenhua | |
773 | 0 |
_tOncotarget _gvol. 7 _gno. 12 _gp. 15033-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.7590 _zAvailable from publisher's website |
999 |
_c25784471 _d25784471 |